Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
STANDARD BIOTOOLS INC. (FLDM)
|
Add to portfolio |
|
|
|
| Price: |
$4.65
| | Metrics |
| OS: |
79.0
|
M
| |
-43
|
% ROE
|
| Market cap: |
$367
|
M
| |
-126
|
% ROIC
|
|
Net cash:
|
$77.1
|
M
| |
$0.98
|
per share
|
|
EV:
|
$290
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($67.1)
|
M
| |
|
|
|
EBIT
|
($81.9)
|
M
| |
|
|
| EPS |
($1.07)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 97.9 | 130.6 | 138.1 | 117.2 | 113.0 | 101.9 | 104.4 | 114.7 |
| Revenue growth | -25.0% | -5.5% | 17.8% | 3.8% | 10.8% | -2.4% | -8.9% | -1.5% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.0 | 46.0 | 46.6 |
| Gross profit | 97.9 | 130.6 | 138.1 | 117.2 | 113.0 | 52.0 | 58.4 | 68.1 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 51.0% | 55.9% | 59.4% |
| Selling, general and administrative | 114.8 | 98.9 | 97.9 | 84.5 | 79.8 | 79.5 | 93.2 | 83.0 |
| Research and development | 38.5 | 37.9 | 36.5 | 31.6 | 30.0 | 30.8 | 38.4 | 39.3 |
| EBITA | -104.7 | -55.5 | -39.1 | -40.6 | -37.0 | -47.2 | -62.0 | -39.0 |
| EBITA margin | -106.9% | -42.5% | -28.3% | -34.7% | -32.7% | -46.3% | -59.4% | -34.0% |
| Amortization of intangibles | 11.5 | 11.9 | 11.9 | 11.2 | 11.2 | 11.2 | 11.2 | 11.2 |
| EBIT | -116.2 | -67.5 | -51.0 | -51.8 | -48.2 | -58.4 | -73.2 | -50.2 |
| EBIT margin | -118.6% | -51.7% | -36.9% | -44.2% | -42.6% | -57.3% | -70.1% | -43.7% |
| Pre-tax income | -192.9 | -63.7 | -54.1 | -66.7 | -61.4 | -63.8 | -80.2 | -54.8 |
| Income taxes | -2.8 | -4.4 | -1.1 | -1.9 | -2.4 | -3.3 | -4.2 | -1.5 |
| Tax rate | 1.5% | 6.9% | 2.0% | 2.9% | 3.9% | 5.1% | 5.2% | 2.7% |
| Net income | -190.1 | -59.2 | -53.0 | -64.8 | -59.0 | -60.5 | -76.0 | -53.3 |
| Net margin | -194.1% | -45.4% | -38.4% | -55.3% | -52.2% | -59.4% | -72.8% | -46.5% |
| |
| Diluted EPS | ($2.43) | ($0.78) | ($0.74) | ($0.97) | ($1.49) | ($1.84) | ($2.62) | ($1.86) |
| Shares outstanding (diluted) | 78.3 | 75.8 | 72.0 | 66.8 | 39.7 | 33.0 | 29.0 | 28.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|